SCHEMBL18993085

SCHEMBL18993085

COC(CCl)COC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16577200 0.85 MAPK1 (0.48) MAPK1
SCHEMBL13482981 0.81 MAPK1 (0.41) MAPK1
SCHEMBL14968999 0.78 MAPK1 (0.42) MAPK1
SCHEMBL18354562 0.78 MAPK1 (0.42) MAPK1
SCHEMBL24658397 0.76 MAPK1 (0.41) MAPK1
SCHEMBL14969322 0.76 MAPK1 (0.41) MAPK1
SCHEMBL17914141 0.76 MAPK1 (0.46) MAPK1
SCHEMBL5765880 0.76 MAPK1 (0.46) MAPK1
SCHEMBL18892556 0.74 MAPK1 (0.39) MAPK1
SCHEMBL9265542 0.74 PRKD3 (0.31) MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2521707-B1 BISPHENOL DERIVATIVES AND THEIR USE AS ANDROGEN RECEPTOR ACTIVITY MODULATORS BRITISH COLUMBIA CANCER AGENCY BRANCH (CA) 2017-06-14 EP disclosed